ClinicalTrials.Veeva

Menu

Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lung Transplantation (Ergo-LTx)

H

Hannover Medical School (MHH)

Status

Unknown

Conditions

Lung Transplantation

Treatments

Behavioral: exercise training; psychosocial support

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00753155
LTx-2778

Details and patient eligibility

About

A prospective, interventional rehabilitation program was initiated to improve exercise capacity and psychosocial functioning in patients after lung transplantation (LTx) and to evaluate long-term effects on health-related quality of life (HRQoL).

Study subjects were randomized to either intervention or to control group and were followed with regular cardiopulmonary exercise testings and HRQoL measurements (SF-36) for 36±3 months after LTx. Patient characteristics did not differ concerning age, gender, and diagnosis at study entry. IG patients received regular psychosocial support and performed a home-based supervised ergometer training program. CG patients were recommended to perform regular exercising.

Enrollment

89 patients

Sex

All

Ages

18 to 67 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Lung transplant (single, double, combined heart-lung) (6-9 mts post Tx)
  • Stable health condition at study entry (pt stays within home environment)
  • Age ≥ 18 yrs
  • Sufficient language skills to answer questionnaire
  • Follow-up at our center
  • Willingness to participate by written informed consent

Exclusion criteria

  • BOS III diagnosis before study inclusion
  • Episodes of recurrent acute rejections
  • Medical contra-indication for regular exercise ergometer training
  • Malignancy
  • Multi-resistent pathogens

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems